APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Analgesics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Opioid Analgesics Market Outlook and Growth Opportunities 2026

30 December 2025199 pages

Choose your research edition.

Industry ResearchOpioid Analgesics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Analgesics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Opioid Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Analgesics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Analgesics Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Opioid Analgesics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Opioid Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Opioid Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Opioid Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Opioid Analgesics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Opioid Analgesics market include Assertio Holdings, Inc, Bausch Health, Boehringer Ingelheim International GmbH, Endo International Plc, F. Hoffmann-La Roche AG, Purdue Pharmaceuticals L.P., Sanofi S.A., Teva Pharmaceuticals and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Opioid Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Opioid Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Opioid Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Opioid Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.

Opioid Analgesics Segment by Company

Assertio Holdings, Inc

Bausch Health

Boehringer Ingelheim International GmbH

Endo International Plc

F. Hoffmann-La Roche AG

Purdue Pharmaceuticals L.P.

Sanofi S.A.

Teva Pharmaceuticals

Abbott Laboratories

Bayer AG

GlaxoSmithKline plc

Pfizer Inc.

Novartis AG

Johnson & Johnson

Opioid Analgesics Segment by Type

Morphine

Methadone

OxyContin

Vicodin

Others

Opioid Analgesics Segment by Application

Surgical Pain

Neuropathic Pain

Cancer Pain

Others

Opioid Analgesics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Opioid Analgesics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Opioid Analgesics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Opioid Analgesics significant trends, drivers, influence factors in global and regions.

6. To analyze Opioid Analgesics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Opioid Analgesics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioid Analgesics industry.

Chapter 3: Detailed analysis of Opioid Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Opioid Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Opioid Analgesics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Opioid Analgesics Industry Trends Table 2. Opioid Analgesics Industry Drivers Table 3. Opioid Analgesics Industry Opportunities and Challenges Table 4. Opioid Analgesics Industry Restraints Table 5. Global Opioid Analgesics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Opioid Analgesics Revenue Share by Company (2021-2026) Table 7. Global Opioid Analgesics Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Opioid Analgesics Sales Volume Share by Company (2021-2026) Table 9. Global Opioid Analgesics Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Opioid Analgesics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Opioid Analgesics Key Company Manufacturing Base & Headquarters Table 12. Global Opioid Analgesics Company, Product Type & Application Table 13. Global Opioid Analgesics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Opioid Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Morphine Table 18. Significant Companies of Methadone Table 19. Significant Companies of OxyContin Table 20. Significant Companies of Vicodin Table 21. Significant Companies of Others Table 22. Global Opioid Analgesics Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 23. Global Opioid Analgesics Sales Volume by Type (2021-2026) & (Tons) Table 24. Global Opioid Analgesics Sales Volume by Type (2027-2032) & (Tons) Table 25. Global Opioid Analgesics Sales Volume Share by Type (2021-2026) Table 26. Global Opioid Analgesics Sales Volume Share by Type (2027-2032) Table 27. Global Opioid Analgesics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Opioid Analgesics Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Opioid Analgesics Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Opioid Analgesics Sales Value Share by Type (2021-2026) Table 31. Global Opioid Analgesics Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Surgical Pain Table 33. Significant Companies of Neuropathic Pain Table 34. Significant Companies of Cancer Pain Table 35. Significant Companies of Others Table 36. Global Opioid Analgesics Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 37. Global Opioid Analgesics Sales Volume by Application (2021-2026) & (Tons) Table 38. Global Opioid Analgesics Sales Volume by Application (2027-2032) & (Tons) Table 39. Global Opioid Analgesics Sales Volume Share by Application (2021-2026) Table 40. Global Opioid Analgesics Sales Volume Share by Application (2027-2032) Table 41. Global Opioid Analgesics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Opioid Analgesics Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Opioid Analgesics Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Opioid Analgesics Sales Value Share by Application (2021-2026) Table 45. Global Opioid Analgesics Sales Value Share by Application (2027-2032) Table 46. Global Opioid Analgesics Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 47. Global Opioid Analgesics Sales by Region (2021-2026) & (Tons) Table 48. Global Opioid Analgesics Sales Market Share by Region (2021-2026) Table 49. Global Opioid Analgesics Sales by Region (2027-2032) & (Tons) Table 50. Global Opioid Analgesics Sales Market Share by Region (2027-2032) Table 51. Global Opioid Analgesics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Opioid Analgesics Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Opioid Analgesics Sales Value Share by Region (2021-2026) Table 54. Global Opioid Analgesics Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Opioid Analgesics Sales Value Share by Region (2027-2032) Table 56. Global Opioid Analgesics Market Average Price (US$/Ton) by Region (2021-2026) Table 57. Global Opioid Analgesics Market Average Price (US$/Ton) by Region (2027-2032) Table 58. Global Opioid Analgesics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 59. Global Opioid Analgesics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 61. Global Opioid Analgesics Sales Market Share by Country (2021-2026) Table 62. Global Opioid Analgesics Sales by Country (2027-2032) & (Tons) Table 63. Global Opioid Analgesics Sales Market Share by Country (2027-2032) Table 64. Global Opioid Analgesics Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Opioid Analgesics Sales Value Market Share by Country (2021-2026) Table 66. Global Opioid Analgesics Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Opioid Analgesics Sales Value Market Share by Country (2027-2032) Table 68. Assertio Holdings, Inc Company Information Table 69. Assertio Holdings, Inc Business Overview Table 70. Assertio Holdings, Inc Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Assertio Holdings, Inc Opioid Analgesics Product Portfolio Table 72. Assertio Holdings, Inc Recent Development Table 73. Bausch Health Company Information Table 74. Bausch Health Business Overview Table 75. Bausch Health Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Bausch Health Opioid Analgesics Product Portfolio Table 77. Bausch Health Recent Development Table 78. Boehringer Ingelheim International GmbH Company Information Table 79. Boehringer Ingelheim International GmbH Business Overview Table 80. Boehringer Ingelheim International GmbH Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio Table 82. Boehringer Ingelheim International GmbH Recent Development Table 83. Endo International Plc Company Information Table 84. Endo International Plc Business Overview Table 85. Endo International Plc Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Endo International Plc Opioid Analgesics Product Portfolio Table 87. Endo International Plc Recent Development Table 88. F. Hoffmann-La Roche AG Company Information Table 89. F. Hoffmann-La Roche AG Business Overview Table 90. F. Hoffmann-La Roche AG Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio Table 92. F. Hoffmann-La Roche AG Recent Development Table 93. Purdue Pharmaceuticals L.P. Company Information Table 94. Purdue Pharmaceuticals L.P. Business Overview Table 95. Purdue Pharmaceuticals L.P. Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio Table 97. Purdue Pharmaceuticals L.P. Recent Development Table 98. Sanofi S.A. Company Information Table 99. Sanofi S.A. Business Overview Table 100. Sanofi S.A. Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Sanofi S.A. Opioid Analgesics Product Portfolio Table 102. Sanofi S.A. Recent Development Table 103. Teva Pharmaceuticals Company Information Table 104. Teva Pharmaceuticals Business Overview Table 105. Teva Pharmaceuticals Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Teva Pharmaceuticals Opioid Analgesics Product Portfolio Table 107. Teva Pharmaceuticals Recent Development Table 108. Abbott Laboratories Company Information Table 109. Abbott Laboratories Business Overview Table 110. Abbott Laboratories Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Abbott Laboratories Opioid Analgesics Product Portfolio Table 112. Abbott Laboratories Recent Development Table 113. Bayer AG Company Information Table 114. Bayer AG Business Overview Table 115. Bayer AG Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Bayer AG Opioid Analgesics Product Portfolio Table 117. Bayer AG Recent Development Table 118. GlaxoSmithKline plc Company Information Table 119. GlaxoSmithKline plc Business Overview Table 120. GlaxoSmithKline plc Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. GlaxoSmithKline plc Opioid Analgesics Product Portfolio Table 122. GlaxoSmithKline plc Recent Development Table 123. Pfizer Inc. Company Information Table 124. Pfizer Inc. Business Overview Table 125. Pfizer Inc. Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Pfizer Inc. Opioid Analgesics Product Portfolio Table 127. Pfizer Inc. Recent Development Table 128. Novartis AG Company Information Table 129. Novartis AG Business Overview Table 130. Novartis AG Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Novartis AG Opioid Analgesics Product Portfolio Table 132. Novartis AG Recent Development Table 133. Johnson & Johnson Company Information Table 134. Johnson & Johnson Business Overview Table 135. Johnson & Johnson Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Johnson & Johnson Opioid Analgesics Product Portfolio Table 137. Johnson & Johnson Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Opioid Analgesics Distributors List Table 141. Opioid Analgesics Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Opioid Analgesics Product Image Figure 2. Global Opioid Analgesics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Analgesics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Opioid Analgesics Sales (2021-2032) & (Tons) Figure 5. Global Opioid Analgesics Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Opioid Analgesics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Morphine Image Figure 10. Methadone Image Figure 11. OxyContin Image Figure 12. Vicodin Image Figure 13. Others Image Figure 14. Global Opioid Analgesics Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Opioid Analgesics Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Opioid Analgesics Sales Volume Share by Type (2021-2032) Figure 17. Global Opioid Analgesics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Opioid Analgesics Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Opioid Analgesics Sales Value Share by Type (2021-2032) Figure 20. Surgical Pain Image Figure 21. Neuropathic Pain Image Figure 22. Cancer Pain Image Figure 23. Others Image Figure 24. Global Opioid Analgesics Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 25. Global Opioid Analgesics Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Opioid Analgesics Sales Volume Share by Application (2021-2032) Figure 27. Global Opioid Analgesics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Opioid Analgesics Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Opioid Analgesics Sales Value Share by Application (2021-2032) Figure 30. Global Opioid Analgesics Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 31. Global Opioid Analgesics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Opioid Analgesics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Opioid Analgesics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Opioid Analgesics Sales Value (2021-2032) & (US$ Million) Figure 35. North America Opioid Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Opioid Analgesics Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Opioid Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Opioid Analgesics Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Opioid Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Opioid Analgesics Sales Value (2021-2032) & (US$ Million) Figure 41. South America Opioid Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Opioid Analgesics Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Opioid Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Opioid Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Opioid Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Opioid Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Opioid Analgesics Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Opioid Analgesics Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Morphine
  • Methadone
  • OxyContin
  • Vicodin
  • Others
Applications
  • Surgical Pain
  • Neuropathic Pain
  • Cancer Pain
  • Others
Companies covered
  • Assertio Holdings, Inc
  • Bausch Health
  • Boehringer Ingelheim International GmbH
  • Endo International Plc
  • F. Hoffmann-La Roche AG
  • Purdue Pharmaceuticals L.P.
  • Sanofi S.A.
  • Teva Pharmaceuticals
  • Abbott Laboratories
  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Opioid Analgesics Sales Value (2021-2032)
  4. 1.2.2 Global Opioid Analgesics Sales Volume (2021-2032)
  5. 1.2.3 Global Opioid Analgesics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Opioid Analgesics Market Dynamics
  1. 2.1 Opioid Analgesics Industry Trends
  2. 2.2 Opioid Analgesics Industry Drivers
  3. 2.3 Opioid Analgesics Industry Opportunities and Challenges
  4. 2.4 Opioid Analgesics Industry Restraints
3 Opioid Analgesics Market by Company
  1. 3.1 Global Opioid Analgesics Company Revenue Ranking in 2025
  2. 3.2 Global Opioid Analgesics Revenue by Company (2021-2026)
  3. 3.3 Global Opioid Analgesics Sales Volume by Company (2021-2026)
  4. 3.4 Global Opioid Analgesics Average Price by Company (2021-2026)
  5. 3.5 Global Opioid Analgesics Company Ranking (2024-2026)
  6. 3.6 Global Opioid Analgesics Company Manufacturing Base and Headquarters
  7. 3.7 Global Opioid Analgesics Company Product Type and Application
  8. 3.8 Global Opioid Analgesics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Opioid Analgesics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Opioid Analgesics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Opioid Analgesics Market by Type
  1. 4.1 Opioid Analgesics Type Introduction
  2. 4.1.1 Morphine
  3. 4.1.2 Methadone
  4. 4.1.3 OxyContin
  5. 4.1.4 Vicodin
  6. 4.1.5 Others
  7. 4.2 Global Opioid Analgesics Sales Volume by Type
  8. 4.2.1 Global Opioid Analgesics Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Opioid Analgesics Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Opioid Analgesics Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Opioid Analgesics Sales Value by Type
  12. 4.3.1 Global Opioid Analgesics Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Opioid Analgesics Sales Value by Type (2021-2032)
  14. 4.3.3 Global Opioid Analgesics Sales Value Share by Type (2021-2032)
5 Opioid Analgesics Market by Application
  1. 5.1 Opioid Analgesics Application Introduction
  2. 5.1.1 Surgical Pain
  3. 5.1.2 Neuropathic Pain
  4. 5.1.3 Cancer Pain
  5. 5.1.4 Others
  6. 5.2 Global Opioid Analgesics Sales Volume by Application
  7. 5.2.1 Global Opioid Analgesics Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Opioid Analgesics Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Opioid Analgesics Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Opioid Analgesics Sales Value by Application
  11. 5.3.1 Global Opioid Analgesics Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Opioid Analgesics Sales Value by Application (2021-2032)
  13. 5.3.3 Global Opioid Analgesics Sales Value Share by Application (2021-2032)
6 Opioid Analgesics Regional Sales and Value Analysis
  1. 6.1 Global Opioid Analgesics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Opioid Analgesics Sales by Region (2021-2032)
  3. 6.2.1 Global Opioid Analgesics Sales by Region: 2021-2026
  4. 6.2.2 Global Opioid Analgesics Sales by Region (2027-2032)
  5. 6.3 Global Opioid Analgesics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Opioid Analgesics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Opioid Analgesics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Opioid Analgesics Sales Value by Region (2027-2032)
  9. 6.5 Global Opioid Analgesics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Opioid Analgesics Sales Value (2021-2032)
  12. 6.6.2 North America Opioid Analgesics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Opioid Analgesics Sales Value (2021-2032)
  15. 6.7.2 Europe Opioid Analgesics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Opioid Analgesics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Opioid Analgesics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Opioid Analgesics Sales Value (2021-2032)
  21. 6.9.2 South America Opioid Analgesics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Opioid Analgesics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Opioid Analgesics Sales Value Share by Country, 2025 VS 2032
7 Opioid Analgesics Country-level Sales and Value Analysis
  1. 7.1 Global Opioid Analgesics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Opioid Analgesics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Opioid Analgesics Sales by Country (2021-2032)
  4. 7.3.1 Global Opioid Analgesics Sales by Country (2021-2026)
  5. 7.3.2 Global Opioid Analgesics Sales by Country (2027-2032)
  6. 7.4 Global Opioid Analgesics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Opioid Analgesics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Opioid Analgesics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Opioid Analgesics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Opioid Analgesics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Opioid Analgesics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Opioid Analgesics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Opioid Analgesics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Opioid Analgesics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Opioid Analgesics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Opioid Analgesics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Opioid Analgesics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Opioid Analgesics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Opioid Analgesics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Opioid Analgesics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Opioid Analgesics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Opioid Analgesics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Opioid Analgesics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Opioid Analgesics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Opioid Analgesics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Opioid Analgesics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Opioid Analgesics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Opioid Analgesics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Opioid Analgesics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Opioid Analgesics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Opioid Analgesics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Opioid Analgesics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Opioid Analgesics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Opioid Analgesics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Opioid Analgesics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Opioid Analgesics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Opioid Analgesics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Opioid Analgesics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Assertio Holdings, Inc
  2. 8.1.1 Assertio Holdings, Inc Company Information
  3. 8.1.2 Assertio Holdings, Inc Business Overview
  4. 8.1.3 Assertio Holdings, Inc Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Assertio Holdings, Inc Opioid Analgesics Product Portfolio
  6. 8.1.5 Assertio Holdings, Inc Recent Developments
  7. 8.2 Bausch Health
  8. 8.2.1 Bausch Health Company Information
  9. 8.2.2 Bausch Health Business Overview
  10. 8.2.3 Bausch Health Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bausch Health Opioid Analgesics Product Portfolio
  12. 8.2.5 Bausch Health Recent Developments
  13. 8.3 Boehringer Ingelheim International GmbH
  14. 8.3.1 Boehringer Ingelheim International GmbH Company Information
  15. 8.3.2 Boehringer Ingelheim International GmbH Business Overview
  16. 8.3.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio
  18. 8.3.5 Boehringer Ingelheim International GmbH Recent Developments
  19. 8.4 Endo International Plc
  20. 8.4.1 Endo International Plc Company Information
  21. 8.4.2 Endo International Plc Business Overview
  22. 8.4.3 Endo International Plc Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Endo International Plc Opioid Analgesics Product Portfolio
  24. 8.4.5 Endo International Plc Recent Developments
  25. 8.5 F. Hoffmann-La Roche AG
  26. 8.5.1 F. Hoffmann-La Roche AG Company Information
  27. 8.5.2 F. Hoffmann-La Roche AG Business Overview
  28. 8.5.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio
  30. 8.5.5 F. Hoffmann-La Roche AG Recent Developments
  31. 8.6 Purdue Pharmaceuticals L.P.
  32. 8.6.1 Purdue Pharmaceuticals L.P. Company Information
  33. 8.6.2 Purdue Pharmaceuticals L.P. Business Overview
  34. 8.6.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio
  36. 8.6.5 Purdue Pharmaceuticals L.P. Recent Developments
  37. 8.7 Sanofi S.A.
  38. 8.7.1 Sanofi S.A. Company Information
  39. 8.7.2 Sanofi S.A. Business Overview
  40. 8.7.3 Sanofi S.A. Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi S.A. Opioid Analgesics Product Portfolio
  42. 8.7.5 Sanofi S.A. Recent Developments
  43. 8.8 Teva Pharmaceuticals
  44. 8.8.1 Teva Pharmaceuticals Company Information
  45. 8.8.2 Teva Pharmaceuticals Business Overview
  46. 8.8.3 Teva Pharmaceuticals Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceuticals Opioid Analgesics Product Portfolio
  48. 8.8.5 Teva Pharmaceuticals Recent Developments
  49. 8.9 Abbott Laboratories
  50. 8.9.1 Abbott Laboratories Company Information
  51. 8.9.2 Abbott Laboratories Business Overview
  52. 8.9.3 Abbott Laboratories Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Abbott Laboratories Opioid Analgesics Product Portfolio
  54. 8.9.5 Abbott Laboratories Recent Developments
  55. 8.10 Bayer AG
  56. 8.10.1 Bayer AG Company Information
  57. 8.10.2 Bayer AG Business Overview
  58. 8.10.3 Bayer AG Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bayer AG Opioid Analgesics Product Portfolio
  60. 8.10.5 Bayer AG Recent Developments
  61. 8.11 GlaxoSmithKline plc
  62. 8.11.1 GlaxoSmithKline plc Company Information
  63. 8.11.2 GlaxoSmithKline plc Business Overview
  64. 8.11.3 GlaxoSmithKline plc Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 GlaxoSmithKline plc Opioid Analgesics Product Portfolio
  66. 8.11.5 GlaxoSmithKline plc Recent Developments
  67. 8.12 Pfizer Inc.
  68. 8.12.1 Pfizer Inc. Company Information
  69. 8.12.2 Pfizer Inc. Business Overview
  70. 8.12.3 Pfizer Inc. Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Pfizer Inc. Opioid Analgesics Product Portfolio
  72. 8.12.5 Pfizer Inc. Recent Developments
  73. 8.13 Novartis AG
  74. 8.13.1 Novartis AG Company Information
  75. 8.13.2 Novartis AG Business Overview
  76. 8.13.3 Novartis AG Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Novartis AG Opioid Analgesics Product Portfolio
  78. 8.13.5 Novartis AG Recent Developments
  79. 8.14 Johnson & Johnson
  80. 8.14.1 Johnson & Johnson Company Information
  81. 8.14.2 Johnson & Johnson Business Overview
  82. 8.14.3 Johnson & Johnson Opioid Analgesics Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Johnson & Johnson Opioid Analgesics Product Portfolio
  84. 8.14.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Opioid Analgesics Value Chain Analysis
  2. 9.1.1 Opioid Analgesics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Opioid Analgesics Sales Mode & Process
  6. 9.2 Opioid Analgesics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Opioid Analgesics Distributors
  9. 9.2.3 Opioid Analgesics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst